نتایج جستجو برای: immunosuppressive therapy

تعداد نتایج: 667447  

2014
Kuang-Hua Chen Tai-Di Chen Chiang-Wen Chen Li-yu Lee

BACKGROUND Kaposi's sarcoma (KS) is an uncommon borderline vascular tumor involving mostly the cutaneous and mucosal sites of the body. Among the four distinctly clinicopathological presentations of KS, the iatrogenic form principally occurs in kidney transplant recipients receiving immunosuppressive therapy. It rarely occurs in the head and neck region as primary site or in other groups of pat...

Journal: :Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2007
Kenji Tajika Taro Mizuki Kazutaka Nakayama Hiroki Yamaguchi Kazuo Dan

Immunosuppressive therapy and stem cell transplantation from an HLA-identical donor are the major effective treatments for severe aplastic anemia. However, treatments still need to be developed for patients who do not have a HLA-identical donor and have not shown a clinical response to immunosuppressive therapy. We herein report on 2 patients in whom this problem could be overcome by transplant...

Journal: :Nephrology Dialysis Transplantation 2023

Abstract Background and Aims IgA Nephropathy is the commonest cause of primary Glomerulonephritis in developed countries. It characterised by IgA-dominant deposits mesangium on renal biopsy. Classically presenting with asymptomatic non-visible haematuria or episodic visible 24-48 hours after an upper respiratory tract infection, raised BP Proteinuria. End-stage disease (ESRD) can occur up to 20...

2017
Junko Yabuuchi Tatsuya Suwabe Hiroki Mizuno Toshiharu Ueno Junichi Hoshino Akinari Sekine Masahiro Kawada Masayuki Yamanouchi Noriko Hayami Rikako Hiramatsu Eiko Hasegawa Naoki Sawa Kenmei Takaichi Takeshi Fujii Kenichi Ohashi Yoshifumi Ubara

A 61-year-old Japanese man developed nephrotic syndrome (NS) due to idiopathic membranous glomerulonephritis (MGN). He received immunosuppressive therapy for two years, including prednisolone, cyclophosphamide, and cyclosporine A, but the NS persisted. Low-density lipoprotein apheresis (LDL-A) was initiated at a frequency of twice a month and continued for 9 years (203 sessions in total). His p...

Journal: :JEADV Clinical Practice 2023

The introduction of immune checkpoint inhibitors and targeted therapies has revolutionized melanoma treatment. downside are immune-mediated adverse events which frequent require close patient management. We report a case severe hepatitis pneumonitis under combined immune-checkpoint inhibitor therapy requiring immunosuppressive therapy. Under therapy, however, series opportunistic infections occ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید